中商官网
研究报告
翰森制药（HK3692）
| 科目\年度 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 |
原始货币 |
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 审计意见 |
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 报表核心指标 |
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 税后利润 |
555546.10 | 437182.50 | 327750.30 | 258374.70 | 271290.20 | 256890.70 | 255674.20 | 190304.80 | 159547.30 | 147603.40 | 144859.10 |
| 营业收入 |
1502832.00 | 1226081.00 | 1010381.00 | 938241.00 | 993514.10 | 869023.40 | 868274.60 | 772227.80 | 618553.70 | 543296.00 | 504517.40 |
| 销售成本 |
149786.70 | 110540.80 | 103086.30 | 86701.00 | 87004.20 | 80156.10 | 72953.99 | 60310.00 | 45517.10 | 39727.90 | 37457.30 |
| 税前利润 |
655058.10 | 508518.20 | 376615.50 | 294842.80 | 330008.20 | 309829.90 | 300092.50 | 230932.50 | 193279.10 | 180427.80 | 169023.30 |
| 归属于母公司股东利润 |
555546.10 | 437182.50 | 327750.30 | 258374.70 | 271290.20 | 256890.70 | 255674.20 | 190304.80 | 159547.30 | 147603.40 | 144859.10 |
| 营业收入 |
1502832.00 | 1226081.00 | 1010381.00 | 938241.00 | 993514.10 | 869023.40 | 868274.60 | 772227.80 | 618553.70 | 543296.00 | 504517.40 |
| 其中：营业额 |
1502832.00 | 1226081.00 | 1010381.00 | 938241.00 | 993514.10 | 869023.40 | 868274.60 | 772227.80 | 618553.70 | 543296.00 | 504517.40 |
| 销售成本 |
149786.70 | 110540.80 | 103086.30 | 86701.00 | 87004.20 | 80156.10 | 72953.99 | 60310.00 | 45517.10 | 39727.90 | 37457.30 |
| 毛利 |
1353046.00 | 1115541.00 | 907294.30 | 851540.00 | 906509.90 | 788867.30 | 795320.60 | 711917.80 | 573036.60 | 503568.10 | 467060.10 |
| 加：其他收入 |
120891.90 | 113333.60 | 112542.40 | 44868.70 | 39318.80 | 32353.10 | 21247.20 | 7795.30 | 9624.40 | 9108.50 | 12356.70 |
| 减：销售费用 |
406379.00 | 379584.80 | 353116.30 | 355023.00 | 342781.80 | 310301.80 | 326638.00 | 320868.00 | 270420.00 | 237804.00 | 224023.00 |
| 管理费用 |
402969.70 | 341419.60 | 280689.00 | 229077.40 | 274043.50 | 201088.70 | 189837.30 | 167144.60 | 118961.90 | 94103.70 | 86369.90 |
| 财务费用 |
316.20 | 668.90 | 6667.90 | 5814.20 | 5281.80 | -- | -- | -- | -- | 341.10 | 0.60 |
| 其他费用 |
9214.60 | -1317.30 | 2748.00 | 11651.30 | -6286.60 | -- | -- | 768.00 | -- | -- | -- |
| 经营溢利 |
655058.10 | 508518.20 | 376615.50 | 294842.80 | 330008.20 | 309829.90 | 300092.50 | 230932.50 | 193279.10 | 180427.80 | 169023.30 |
| 税前利润 |
655058.10 | 508518.20 | 376615.50 | 294842.80 | 330008.20 | 309829.90 | 300092.50 | 230932.50 | 193279.10 | 180427.80 | 169023.30 |
| 减：所得税费用 |
99512.00 | 71335.70 | 48865.20 | 36468.10 | 58718.00 | 52939.20 | 44418.30 | 40627.70 | 33731.80 | 32824.40 | 24164.20 |
| 税后利润 |
555546.10 | 437182.50 | 327750.30 | 258374.70 | 271290.20 | 256890.70 | 255674.20 | 190304.80 | 159547.30 | 147603.40 | 144859.10 |
| 归属于母公司股东利润 |
555546.10 | 437182.50 | 327750.30 | 258374.70 | 271290.20 | 256890.70 | 255674.20 | 190304.80 | 159547.30 | 147603.40 | 144859.10 |
| 基本每股收益 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- | -- | -- |
| 稀释每股收益 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- | -- | -- |
| 其他综合收益 |
-58367.89 | 23444.70 | 42792.10 | 63288.60 | -20140.30 | -97819.40 | 18528.60 | 4616.00 | -5112.10 | 7538.70 | -- |
| 综合收益总额 |
497178.20 | 460627.20 | 370542.40 | 321663.30 | 251149.90 | 159071.30 | 274202.80 | 194920.80 | 154435.20 | 155142.10 | 144859.10 |
| 归属于母公司股东综合收益总额 |
497178.20 | 460627.20 | 370542.40 | 321663.30 | 251149.90 | 159071.30 | 274202.80 | 194920.80 | 154435.20 | 155142.10 | 144859.10 |